Metabolic Syndrome Clinical Trial
Official title:
A Clinical Trial on the Prevention of Coronary Artery Disease, Insulin Resistance and Hyperlipidemia in Black Women With Meditation and Health Education
Verified date | May 2024 |
Source | Maharishi International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized controlled trial compared the efficacy of stress reduction with meditation to a health education (HE) group in 201 older African American women over a one-year study period. They were randomly allocated to either of two behavioral treatment groups-1) the Transcendental Meditation (TM( program or 2) a health education (HE) program. Women participants were recruited, tested, and instructed at two clinical sites: Washington, DC and Atlanta, GA. Outcome measures were carotid intima medial thickness, lipid profile, glucose and insulin resistance, and behavioral factors.
Status | Completed |
Enrollment | 201 |
Est. completion date | November 2004 |
Est. primary completion date | November 2004 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 55 Years and older |
Eligibility | Inclusion Criteria: - African American women, - age 55 or older with at least one of the five cardiovascular conditions (below): - coronary heart disease or - positive coronary angiography or - previous MI or - coronary revascularization or - percutaneous transluminal coronary angioplasty (PTCA). These conditions were medically documented for the study eligibility and subsequent randomization. In the absence of these CAD markers: a high risk factor assessment score of at least two points based on the Framingham study/ATP III report was also accepted for eligibility. Risk factors included diabetes, high systolic or diastolic BP, high cholesterol, high LDL-low HDL or smoking. Exclusion Criteria: - Myocardial infarction - unstable angina - coronary artery by-pass grafting (CABG) - percutaneous transluminal coronary angioplasty (PTCA) - stroke within the preceding three months - carotid artery endarterectomy - atrial fibrillation - second or third degree AV block - heart failure - clinically significant valvular heart disease - major psychiatric disorders, - current alcohol/dependency disorder - other drug abuse dependency disorder - non-cardiac life-threatening illness - participating in a formal stress management program - plans to move out of the study area or travel extensively - unwillingness to accept randomization into any study group. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Robert Schneider, MD | Howard University, Morehouse School of Medicine |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | carotid intima medial thickness | B mode ultrasound measure of carotid artery wall thickness | 0 and 12 months | |
Secondary | insulin resistance and glucose | using the HOMA index | 0 and 12 months | |
Secondary | lipid profile | LDL, HDL, total cholesterol (TC), triglycerides (TG) (for LDL, TC and TG), a higher score indicates a worst outcome, for HDL a higher score indicates a better outcome | 0 and 12 months | |
Secondary | blood pressure | measured three times with a mercury sphygmomanometer 5 minutes apart and last two reading averaged | 0, 4 and 12 months | |
Secondary | general perceived health | SF-36 (numerical likert scale and YES/NO response categories are variable in terms of indicating a better or worse outcome) | 0, 4 and 12 months | |
Secondary | Dietary habits | block diet questionaire (food choice with pictures) not scaled to indicate a better or worse outcome) | 0, 4 and 12 months | |
Secondary | Physical Activity | Exercise --using the Folsom Physical Activity Questionaire--not scaled to indicate a better or worse outcome | 0, 4 and 12 months | |
Secondary | Substance use | substance usage questionnaire for alcohol and illicit drug usage | 0, 4 and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |